Qualcomm brings wireless data capture to Johnson & Johnson glucose meters

Qualcomm and LifeScan's agreement will facilitate physician access to glucose meter data.

Qualcomm and Johnson & Johnson’s LifeScan unit have teamed up to enable wireless data collection for one of the latter’s blood glucose meters.

Under the agreement, Qualcomm Life’s 2net solution will allow cable-free data capture for physicians caring for patients using LifeScan’s OneTouch Verio Flex blood glucose meters

Patients may easily sync their glucose data via Bluetooth to the accompanying OneTouch Reveal mobile app, but physicians trying to access this data have a harder time. They have to do so manually, in a process that requires “multiple cables and software versions,” Qualcomm said in a statement.


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Qualcomm’s 2net platform allows the Verio Flex meter to send data to the cloud, so that physicians may access a patient’s historical and recent blood glucose data on which to base care decisions, according to the statement.

"Enabling timely access to blood glucose data generates actionable insights for physicians and patients for more informed diabetes care management," said Rick Valencia, president of Qualcomm’s Qualcomm Life subsidiary, in the statement. "The secure, wireless data capture that 2net provides is valuable for clinicians as they seek transformative ways to treat people with diabetes efficiently and effectively across the care continuum."

RELATED: Philips, Qualcomm partner on personalized, connected health

The duo plans a limited rollout of the 2net solution to physicians’ offices this fall, and to introduce it globally in 2018.

This isn’t Qualcomm’s first partnership with a major diabetes device maker—in May last year, the company joined forces with Medtronic to create an affordable, wireless, disposable continuous glucose monitor.

Suggested Articles

Janssen is planning its first completely virtual clinical trial, using personal smartphones and wearable devices with no in-person site visits.

Sensyne Health aims to bring its AI tools to America, and it’s enlisting IT giant Cognizant and data infrastructure specialist Agorai to help.

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.